ANDA 72923, held by Watson Labs. Verapamil Hydrochloride.
As of Nov 16, 2026, ANDA 72923 (Verapamil Hydrochloride), held by Watson Labs, was first approved by FDA on Jun 29, 1993, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 29, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Verapamil Hydrochloride40MG ยท tablet;oral | Verapamil Hydrochloride | Discontinued |
| Apr 19, 2007 | Supplement 8Manufacturing | Approved | None posted |
| Nov 7, 2002 | Supplement 6Manufacturing | Approved | None posted |
| May 21, 2002 | Supplement 5Manufacturing | Approved | None posted |
| Sep 5, 2001 | Supplement 4Manufacturing | Approved | None posted |
| Nov 10, 1999 | Supplement 3Manufacturing | Approved | None posted |
| Aug 26, 1998 | Supplement 2Labeling | Approved | None posted |
| Apr 10, 1996 | Supplement 1Labeling | Approved | None posted |
| Jun 29, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters